drugset / Trial / NCT01188824
The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study)
Phase 4
Completed
801 enrolled
China Medical University Hospital
Cathay General Hospital · collabChanghua Christian Hospital · collabChi Mei Medical Hospital · collabChung Shan Medical University · collabE-DA Hospital · collabEn Chu Kong Hospital · collabFar Eastern Memorial Hospital · collabKaohsiung Medical University Chung-Ho Memorial Hospital · collabKuang Tien General Hospital · collabMackay Memorial Hospital · collabNational Cheng-Kung University Hospital · collabNational Taiwan University Hospital · collabShin Kong Wu Ho-Su Memorial Hospital · collabTaipei Veterans General Hospital, Taiwan · collabTri-Service General Hospital (TSGH) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate the Safety and Efficacy of Cilostazol in slowing down the progression of peripheral arterial disease (PAD) in ischemic stroke patients with PAD in Taiwan.
Timeline
- Start
- 2010-09
- Primary completion
- 2013-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cilostazol | Small molecule | 100 mg | Oral |